Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Biotech 'Thinking Several Steps Ahead with Optimizing IVR Quality Control

The company's latest science, presented at a recent conference, is discussed in a ROTH Capital Partners report. In a July 31 research note, ROTH Capital Partners analyst Yasmeen Rahimi reported that Daré Bioscience Inc. (DARE:NASDAQ) presented two posters o...

Tariffs Are Having a Bigger Effect on U.S. Manufacturing Than Initially Thought

The U.S. manufacturing sector contracted for the fifth straight month in December, with the monthly reading from the Institute for Supply Management (ISM) hitting its weakest point in more than 10 years. The purchasing manager’s index (PMI) fell to 47.2,...

Could Hong Kong Disrupt China & The Global Markets Further?

Reading the news this weekend and watching the chaos in Hong Kong, one has to wonder how this violence and disruption in commerce is really affecting the Asian and global markets. Many different news sources are already reporting that Chinese economic data continues to show w...

MyoKardia Shares Get a Jolt from Positive Phase 3 HCM Clinical Trial Results

Shares of MyoKardia traded 60% higher, setting a new 52-week high price, after the company reported that it met all primary and secondary endpoints in the Phase 3 EXPLORER study of mavacamten in treatment of obstructive hypertrophic cardiomyopathy. Clinical-...

Is the Stock Selloff Over Now?

Some would call yesterday’s session Black Monday. Little wonder as the S&P 500 finished down more than 100 points from Friday’s closing bell. The overnight recovery in the futures gave up most of its gains, and stocks are again hanging close to ...

Solving the Hemp Extraction Problem created by the US Farm Bill

A CONVERSATION WITH NICK KIMBALL, PRESIDENT AND CEO, CASCADIA EXTRACTS, and AARON WILLIAMS, EXECUTIVE VICE PRESIDENT, CASCADIA EXTRACTS MOTIVATION What was your motivation to enter the hemp market in 2019? KIMBALL : Two years ago, the cannabis market ...

Novamind’s Trial Site for Merck Another Example Of Its Leadership in Mental Health

Novamind’s clinics and clinical research capabilities are already well established to bring alternative mental health therapies, including psychedelic medicine, to market. One of the world’s largest pharmaceutical companies has selected ...

Krill oil boom is real

There’s a new type of oil that’s causing a major stir in the markets. This oil boom has nothing to do with crude oil or energy though. But it still has the potential to be just as profitable. I’m talking about krill oil. ...

Profiting from Europe's new gold rush

Europe owns a sizable chunk of the world's natural resources. Over the past few decades, however, EU countries have mostly imported their resources. Outlandish? Maybe. But it was simply easier, cheaper, and most importantly it avoided most environmental conflicts. Ge...

Canadian mining, oil & gas have a lot to lose from minority government

In mid-August, a ground-breaking ceremony of sorts took place in Edmonton for the Trans Mountain Pipeline project . Natural Resources Minister Amarjeet Sohi picked the yard of pipeline contractor SA Energy to announce that Trans Mountain Corp. is moving forward to constr...
1 2